HyalOne

HyalOne is a temporary synovial fluid substitute for patients suffering from degenerative or traumatic arthropathy of the hip and knee joints, which entails a change in the functional characteristics of the synovial fluid, without active synovitis.

The introduction of the product should be carried out exclusively by a qualified doctor. All rules regarding aseptic and injection techniques must be followed. Before the introduction, eliminate all the discharge of the joint, if any.

Additional courses of treatment after the first application may be required in order to maintain the benefits of treatment for a long time, depending on the individual needs of the patient.

Inject HyalOne using an appropriate sterile 18 G or 20 G needle.

If HyalOne is used for the hip joint, it is recommended to perform an injection under ultrasound guidance. This is not necessary if HyalOne is used for the knee joint.

The sterility of the outer surface of the syringe makes the product suitable for use in the operating room.

It cannot be administered to patients with confirmed individual hypersensitivity to the components of the product and in cases of infections or skin diseases in the areas of injection sites. There is no evidence of contraindications for re-treatment.

Active substance: 4 ml of the solution contain 60 mg of sodium salt of hyaluronic acid.

Excipients: sodium chloride, sodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injection.

1 pre-filled syringe in a cardboard box.

Each syringe is hermetically sealed in a blister sterilized with ethylene oxide and contains a thermally sterilized solution of sodium salt of hyaluronic acid 60 mg / 4 ml.

Fidia Farmaceutici S.p.A., Via Ponte della Fabbrica 3/A, 35031 Abano Terme (PD), Italy.

№UA.MD.099-17.